BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35173297)

  • 21. T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response.
    Van Loo P; Tousseyn T; Vanhentenrijk V; Dierickx D; Malecka A; Vanden Bempt I; Verhoef G; Delabie J; Marynen P; Matthys P; De Wolf-Peeters C
    Haematologica; 2010 Mar; 95(3):440-8. PubMed ID: 19797726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flow Cytometric Detection of the Double-Positive (CD4+CD8+)/PD-1bright T-Cell Subset Is Useful in Diagnosing Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
    Chen ZW; Wizniak J; Shang C; Lai R
    Arch Pathol Lab Med; 2022 Jun; 146(6):718-726. PubMed ID: 34506624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Nodular lymphocyte-predominant Hodgkin's lymphoma and differential diagnoses].
    Hartmann S; Cogliatti S; Hansmann ML
    Pathologe; 2013 May; 34(3):233-43. PubMed ID: 23494280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclin D1 expression and polysomy in lymphocyte-predominant cells of nodular lymphocyte-predominant Hodgkin lymphoma.
    Cho BB; Kelting SM; Gru AA; LeGallo RD; Pramoonjago P; Goldin TA; Heitz CT; Aguilera NS
    Ann Diagn Pathol; 2017 Feb; 26():10-15. PubMed ID: 28038705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small intestinal presentation of nodular lymphocyte-predominant Hodgkin lymphoma with T cell/histiocyte-rich B cell lymphoma-like areas-with review of literature on extranodal presentation of this disease.
    Bagwan IN; Knee G; Abboudi Z; Naresh KN
    J Hematop; 2010 Mar; 3(1):29-34. PubMed ID: 21436871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nodular Lymphocyte Predominant Hodgkin Lymphoma versus T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Diagnostic Challenge.
    Rets AV; Gottesman SR
    Case Rep Pathol; 2014; 2014():956217. PubMed ID: 25110597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas.
    Tian X; Xu J; Dorfman DM
    Am J Surg Pathol; 2019 Jan; 43(1):102-109. PubMed ID: 30371509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.
    Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA
    Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone Marrow Involvement in Patients With Nodular Lymphocyte Predominant Hodgkin Lymphoma.
    Agbay RLMC; Loghavi S; Zuo Z; Fayad L; Dabaja B; Medeiros LJ; Khoury JD
    Am J Surg Pathol; 2018 Apr; 42(4):492-499. PubMed ID: 29309302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma?
    Barber NA; Loberiza FR; Perry AM; Bast M; Holdeman KP; Esfahane AB; Weisenburger DD; Vose J; Bierman P; Armitage JO; Bociek RG
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):392-7. PubMed ID: 23773450
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Schuhmacher B; Bein J; Rausch T; Benes V; Tousseyn T; Vornanen M; Ponzoni M; Thurner L; Gascoyne R; Steidl C; Küppers R; Hansmann ML; Hartmann S
    Haematologica; 2019 Feb; 104(2):330-337. PubMed ID: 30213827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-cell/histiocyte-rich large B-cell lymphoma in pediatric patients: an under-recognized entity?
    Gheorghe G; Rangarajan HG; Camitta B; Segura A; Kroft S; Southern JF
    Ann Clin Lab Sci; 2015; 45(1):73-8. PubMed ID: 25696014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell/histiocyte-rich large B-cell lymphoma associated with a near-tetraploid karyotype and complex genetic abnormalities.
    de Leval L; Harris NL; Lampertz S; Herens C
    APMIS; 2006 Jun; 114(6):474-8. PubMed ID: 16856972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic tumor volume, cancer cell fraction, and prognosis - the case of T-cell/histiocyte-rich large B-cell lymphoma.
    Schmitz C; Rekowski J; Reinke S; Müller SP; Hüttmann A; Klapper W; Dührsen U
    Leuk Lymphoma; 2020 Jun; 61(6):1372-1379. PubMed ID: 32022621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis.
    Churchill HR; Roncador G; Warnke RA; Natkunam Y
    Hum Pathol; 2010 Dec; 41(12):1726-34. PubMed ID: 20825974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Review of the Flow Cytometric Findings in Classic Hodgkin Lymphoma, Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte-Rich Large B Cell Lymphoma.
    Ally F; Gajzer D; Fromm JR
    Clin Lab Med; 2023 Sep; 43(3):427-444. PubMed ID: 37481321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pitfalls in the Diagnosis of Nodular Lymphocyte Predominant Hodgkin Lymphoma: Variant Patterns, Borderlines and Mimics.
    Younes S; Rojansky RB; Menke JR; Gratzinger D; Natkunam Y
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34208705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphologic, immunphenotypic and clinical discriminators between T-cell/histiocyte-rich large B-cell lymphoma and lymphocyte-predominant Hodgkin lymphoma.
    Mourad WA; Al Thani S; Tbakhi A; Al Omari M; Khafaga Y; Shoukri M; El Weshi A; Al Shabana M; Ezzat A
    Hematol Oncol Stem Cell Ther; 2008; 1(1):22-7. PubMed ID: 20063524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From a pathologist's point of view: Histiocytic cells in Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma.
    Hartmann S
    Pathol Res Pract; 2015 Dec; 211(12):901-4. PubMed ID: 26596262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade.
    Tabanelli V; Melle F; Motta G; Mazzara S; Fabbri M; Agostinelli C; Calleri A; Del Corvo M; Fiori S; Lorenzini D; Cesano A; Chiappella A; Vitolo U; Derenzini E; Griffin GK; Rodig SJ; Vanazzi A; Sabattini E; Tarella C; Sapienza MR; Pileri SA
    Blood Adv; 2022 Aug; 6(15):4634-4644. PubMed ID: 35767735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.